No definition available.
Adenocarcinomas of cervix, excluding all cancers (controls excluding all cancers)
C3_CERVIX_ADENO_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
150 |
4. Check minimum number of eventsNone |
150 |
5. Include endpointsNone |
150 |
6. Filter based on genotype QC (FinnGen only) |
150 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Adenocarcinomas of cervix, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Adenocarcinomas of cervix
- Malignant neoplasm of cervix uteri
- Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)
- malignant neoplasm of female genital organs
- malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 150 | 150 | - |
| Unadjusted period prevalence (%) | 0.05 | 0.05 | - |
| Median age at first event (years) | 42.97 | 42.97 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 154
- Matched controls
- 1540
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C53.02
ICD-10 Finland
Adenocarcinoma of the endocervix
+∞
135.0
109
*
8140/3-C53.9
ICD-O-3
Adenocarcinoma, NOS, of cervix uteri
+∞
112.8
94
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
59.3
53
*
8140/3-C53.0
ICD-O-3
Adenocarcinoma, NOS, of endocervix
+∞
54.5
49
*
ULA02
NOMESCO Finland
Kolposcopy
17.5
51.5
96
133
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
24.4
49.4
74
56
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
42.7
39
*
LCD31
NOMESCO Finland
Radical laparoscopic hysterectomy
+∞
40.4
37
*
C53.12
ICD-10 Finland
Adenocarcinoma of the exocervix
+∞
40.4
37
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
11.4
38.5
88
161
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
11.9
37.3
80
128
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
34.7
32
*
H02AB02
ATC
dexamethasone; systemic
46.8
32.5
39
11
ZXC96
NOMESCO Finland
Robot assisted procedure
387.2
32.1
31
*
PJA01
NOMESCO Finland
Laparoscopic sentinel node excision
+∞
31.3
29
*
LEB00
NOMESCO Finland
Biopsy of vagina
40.0
29.8
37
12
WF002
NOMESCO Finland
Radical radiotherapy
324.8
27.7
27
*
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
10.3
27.3
59
87
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
73.8
27.1
30
5
B01AB10
ATC
tinzaparin; parenteral
19.0
24.6
38
26
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
25.3
24.3
34
17
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
46.3
22.6
27
7
A04AA55
ATC
palonosetron, combinations; systemic
+∞
22.4
21
*
D06.0
ICD-10 Finland
Carcinoma in situ: Endocervix
134.2
22.2
23
*
LCD30
NOMESCO Finland
Radical hysterectomy
254.7
22.2
22
*
A03FA01
ATC
metoclopramide; systemic, rectal
7.0
22.2
64
142
JN4BD
NOMESCO Finland
Extensive body CT
18.6
22.0
34
23
XX3DW
NOMESCO Finland
Time consuming IT work
15.8
21.8
36
29
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
+∞
21.3
20
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
21.3
20
*
LDA10
NOMESCO Finland
Curettage of cervix uteri
11.9
21.0
40
44
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
228.1
20.1
20
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
5.0
18.9
82
286
121
Kela drug reimbursment
Severe hypofunction of sexual glands
22.0
18.1
26
14
C53.00
ICD-10 Finland
Malignant tumor of endocervix without histology
+∞
18.1
17
*
A04AA02
ATC
granisetron; systemic, transdermal
107.6
18.0
19
*
TLW99
NOMESCO Finland
Other minor surgical procedure in gynaecology
16.8
17.6
28
20
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
17.0
16
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
17.0
16
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
17.0
16
*
B01AB05
ATC
enoxaparin; parenteral
4.5
16.1
73
256
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
15.9
15
*
C53.0
ICD-10 Finland
Malignant neoplasm: Endocervix
+∞
15.9
15
*
C53.01
ICD-10 Finland
Squamous cell carcinoma of the endocervix
+∞
15.9
15
*
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
12.9
15.8
28
26
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
20.5
15.7
23
13
A04AA01
ATC
ondansetron; systemic, rectal
14.0
15.3
26
22
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
14.8
14
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
59.1
14.1
16
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
152.9
13.7
14
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
152.9
13.7
14
*
ZX020
NOMESCO Finland
HDR radiotherapy within tissue
+∞
12.7
12
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
12.7
12
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
12.7
12
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
12.7
12
*
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
4.4
11.9
48
143
LCA06
NOMESCO Finland
Biopsy of endometrium
4.5
11.6
46
134
8140/3-C53.1
ICD-O-3
Adenocarcinoma, NOS, of exocervix
+∞
11.6
11
*
C53.09
ICD-10 Finland
Malignant tumor of endocervix, unspecified histology
+∞
11.6
11
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
11.6
11
*
ZX040
NOMESCO Finland
Intracavity HDR radiotherapy
+∞
11.6
11
*
A04AD12
ATC
aprepitant; systemic
+∞
11.6
11
*
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
30.5
10.9
14
5
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
117.7
10.6
11
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
10.5
10
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
10.5
10
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
10.5
10
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.8
10.1
49
170
WZC30
NOMESCO Finland
Teaching
5.5
9.9
30
65
ZXE30
NOMESCO Finland
More than five and less than seven hours
11.2
9.8
18
18
WX402
NOMESCO Finland
General anaesthesia
4.3
9.8
39
113
C53.11
ICD-10 Finland
Squamous cell carcinoma and exocervix
+∞
9.5
9
*
C53
ICD-10 Finland
Malignant neoplasm of cervix uteri
+∞
9.5
9
*
C53.92
ICD-10 Finland
Adenocarcinoma in an unspecified location in the cervix
+∞
9.5
9
*
1800A
ICD-9 Finland
Malignant neoplasm of cervix uteri, Endocervix
+∞
9.5
9
*
UKC02
NOMESCO Finland
Cystoscopy
4.5
8.5
31
82
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
95.0
8.5
9
*
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
95.0
8.5
9
*
ZXE20
NOMESCO Finland
More than three and less than five hours
4.6
8.5
30
77
8310
FHL
Radical hysterectomy (includes lymph node removal)
+∞
8.4
8
*
TPH07
NOMESCO Finland
Cathetrisation of artery
6.6
8.3
21
36
WX302
NOMESCO Finland
Thoracal epidural anesthesy
9.8
8.3
16
18
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.7
8.2
80
437
YX9VG
NOMESCO Finland
Other MRI eamination with high intensity magnet for dose design of radiotherapy
+∞
7.3
7
*
C53.90
ICD-10 Finland
Malignant tumor in unspecified localization in cervix uteri without histology
+∞
7.3
7
*
C53.99
ICD-10 Finland
Malignant tumor in unspecified localization in cervix, unspecified histology
+∞
7.3
7
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
21.2
7.2
10
5
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
21.2
7.2
10
5
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
31.6
7.2
9
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
8.9
7.0
14
17
P01AB01
ATC
metronidazole; oral, rectal
2.5
6.9
85
513
Z51.5
ICD-10 Finland
Palliative care
17.7
6.8
10
6
LBE10
NOMESCO Finland
Bilateral salpingectomy
42.0
6.8
8
*
8077/2-C53.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of cervix uteri
8.0
6.6
14
19
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
72.7
6.5
7
*
KA1FN
NOMESCO Finland
Isotope renography
72.7
6.5
7
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
72.7
6.5
7
*
WW500
NOMESCO Finland
Blood transfusion
11.7
6.4
11
10
JN2BG
NOMESCO Finland
MRI examination of lower part of abdoment with high intensity magnet
19.0
6.3
9
5
C53.9
ICD-10 Finland
Malignant neoplasm: Cervix uteri, unspecified
+∞
6.3
6
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
6.3
6
*
TKD00
NOMESCO Finland
Dilatation of urethra
+∞
6.3
6
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
6.3
6
*
C53.1
ICD-10 Finland
Malignant neoplasm: Exocervix
+∞
6.3
6
*
K52.0
ICD-10 Finland
Gastroenteritis and colitis due to radiation
+∞
6.3
6
*
JN5JS
NOMESCO Finland
Extensive PET-MRI of body metabolism
+∞
6.3
6
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
N02BE01
ATC
paracetamol; systemic, rectal
3.6
6.1
141
1157
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
40
31
17.23
43.47
1.7
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
41
71
7.57
24.25
2.4
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
22
29
8.72
16.14
1.6
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
81
352
3.83
14.93
2.5
1.4
—
—
—
0
0
(4281824)
17
7
27.14
12.78
1.1
1.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
32
91
4.20
10.46
2.4
3.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
79
408
2.98
9.88
4.0
2.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
55
234
3.13
9.69
4.5
3.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
86
479
2.86
9.14
2.8
1.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
104
645
3.00
8.95
6.4
5.0
estimate
0.0
0.0
0.00
26
109
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
93
544
2.87
8.93
4.9
3.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
67
337
2.79
8.52
2.1
1.9
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
103
649
2.87
8.36
4.9
3.6
estimate
0.0
0.0
0.00
25
110
(3015736) pH of Urine
88
512
2.74
8.35
4.1
3.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
27
81
3.85
8.12
1.8
1.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
104
671
2.79
7.85
13.1
7.0
e9/l
3.9
4.2
0.67
96
575
(3002256) Pathology report gross observation
31
105
3.46
7.79
1.5
1.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
77
433
2.60
7.63
4.8
3.5
e6/l
116.9
111.1
0.04
54
282
(3000850) Epithelial cells [#/volume] in Urine
52
242
2.76
7.53
2.7
2.3
e6/l
11.0
7.2
0.79
41
209
(3035350) Ketones [Presence] in Urine by Test strip
100
643
2.67
7.42
5.0
3.6
estimate
0.0
0.0
0.00
26
112
(3026008) Bacteria identified in Urine by Culture
73
416
2.47
6.84
4.9
3.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
79
468
2.45
6.78
6.6
3.5
g/l
34.6
36.6
2.21
73
432
(3002582) Erythrocytes [#/volume] in Urine
64
348
2.46
6.59
3.9
2.8
e6/l
31.1
51.8
0.50
52
252
(36304419) Bacteria [Presence] in Urine
60
318
2.48
6.52
3.7
2.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
60
325
2.41
6.15
5.5
4.0
estimate
0.0
0.0
0.00
25
112
(3031040) Bacteria [#/volume] in Urine by Automated count
117
856
2.67
5.98
6.6
4.7
e6/l
2638.3
2472.4
—
7
12
(3011397) Hemoglobin [Presence] in Urine by Test strip
55
291
2.41
5.90
4.7
3.7
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
9
7
13.57
5.66
1.0
1.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
57
318
2.28
5.33
3.8
2.7
e6/l
0.5
0.5
0.16
45
225
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
22
78
3.13
5.07
3.1
2.2
g/l
0.2
0.2
1.28
22
73
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
86
575
2.16
5.05
7.7
3.3
umol/l
7.9
10.2
3.27
81
531
(40758558) Short blood count panel - Blood
52
286
2.25
4.98
11.6
5.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
118
910
2.39
4.67
9.2
5.0
u/l
81.5
75.8
0.45
112
829
(40761536) Microorganisms panel - Urine sediment
24
98
2.72
4.31
5.6
3.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
36
188
2.20
3.81
3.1
2.4
e6/l
0.9
1.2
0.64
21
97
(40761535) Cells panel - Urine sediment
23
98
2.59
3.80
3.8
3.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
17
63
2.92
3.63
2.3
5.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
61
394
1.92
3.61
4.9
8.6
inr
1.1
1.3
2.45
20
116
(3037467) Urinalysis macro (dipstick) panel - Urine
114
911
2.05
3.48
6.7
4.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
43
249
2.02
3.46
2.2
1.8
—
—
—
0
0
(3044889) 12 lead EKG panel
106
834
1.92
3.28
3.3
3.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
72
506
1.81
3.18
5.2
3.7
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
71
497
1.81
3.17
4.5
3.9
mmol/l
1.2
1.2
0.48
62
442
(3019060) Gas panel - Arterial blood
15
56
2.87
3.16
3.8
4.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
7
12
6.06
3.05
1.4
1.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
88
664
1.79
3.00
3.5
3.4
mmol/l
6.2
6.5
0.99
80
602
(3003694) ABO and Rh group [Type] in Blood
52
337
1.83
2.95
1.7
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
24
121
2.17
2.74
1.4
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
72
524
1.72
2.69
11.3
7.5
e9/l
0.0
0.0
1.09
60
422
(42870588) Differential panel, method unspecified - Blood
57
390
1.74
2.65
5.2
5.5
—
—
—
0
0
(3026782) Osmolality of Urine
38
231
1.86
2.60
2.9
2.3
mosm/kgh2o
512.1
547.6
0.41
32
190
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
16
70
2.44
2.51
1.9
1.4
—
—
—
0
0
(1002224) Polysomnography panel
0
67
0.00
2.46
0.0
1.1
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
12
46
2.75
2.42
3.1
5.4
%
0.7
0.7
0.20
12
46
(3003396) Base excess in Arterial blood by calculation
20
99
2.18
2.39
3.8
4.8
mmol/l
0.7
1.5
0.55
12
79
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
12
47
2.69
2.33
3.1
5.3
%
1.2
1.3
0.08
12
47
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
30
176
1.88
2.28
3.3
2.7
e6/l
2.7
5.2
0.99
18
87
(3033658) Prothrombin time (PT) actual/Normal
41
272
1.70
2.07
5.0
2.8
%
100.4
94.5
0.88
41
262
(3014007) Fractional oxyhemoglobin in Arterial blood
11
44
2.62
2.06
3.3
5.7
%
96.9
94.7
3.42
11
44
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
113
1261
0.58
2.05
3.5
4.0
mmol/l
1.6
1.6
0.87
106
1172
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
73
561
1.59
2.05
5.7
4.3
mmol/l
1.2
1.2
1.30
59
487
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
114
1268
0.58
2.01
3.6
4.1
mmol/l
5.0
4.8
1.36
107
1184
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
11
46
2.50
1.90
4.5
5.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
6
17
3.63
1.85
1.5
1.8
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
13
60
2.28
1.84
3.3
2.4
u/l
368.7
3280.7
—
7
26
(3019198) Lymphocytes [#/volume] in Blood
78
620
1.54
1.83
5.4
5.5
e9/l
1.6
2.0
4.02
67
544
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
138
1263
2.16
1.81
19.3
10.8
mg/l
30.2
19.0
2.63
118
946
(3001604) Monocytes [#/volume] in Blood
76
605
1.52
1.74
5.4
5.4
e9/l
0.5
0.6
0.67
66
522
(3044941) Cell count panel - Synovial fluid
5
13
3.94
1.73
1.4
1.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
23
136
1.82
1.71
9.6
5.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
44
312
1.58
1.69
2.6
2.2
mg/l
3.3
3.0
0.25
38
271
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
7
25
2.89
1.67
1.4
1.3
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
76
609
1.50
1.67
5.4
5.4
e9/l
0.0
0.0
1.80
65
522
(3020891) Body temperature
8
32
2.58
1.62
3.4
4.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
118
1288
0.61
1.61
3.9
4.6
mmol/l
2.9
2.8
0.51
110
1196
(3042936) Bacteria identified in Isolate by Culture
24
147
1.75
1.59
2.2
1.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
50
373
1.51
1.52
4.3
3.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
21
126
1.78
1.50
1.9
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
5
16
3.19
1.45
1.0
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
18
104
1.83
1.44
1.8
1.6
—
—
—
0
0
(3012544) pH of Venous blood
17
97
1.85
1.42
2.4
3.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
104
1158
0.67
1.41
4.4
5.2
mmol/mol
37.9
38.8
0.48
97
1084
(3013115) Eosinophils [#/volume] in Blood
77
634
1.44
1.40
5.7
6.0
e9/l
0.2
0.2
0.89
67
558
(3018418) pH of Serum or Plasma
46
345
1.48
1.35
3.3
2.6
ph
7.4
7.4
—
9
46
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
24
2.56
1.31
1.0
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
24
2.56
1.31
1.0
1.2
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
8
34
2.43
1.31
2.8
2.7
mmol/l
1.2
1.3
—
8
34
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
19
2.69
1.22
1.2
1.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
8
154
0.49
1.22
1.4
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
6
26
2.36
1.20
3.2
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
30
2.40
1.14
1.4
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
17
105
1.70
1.12
1.8
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
111
1205
0.70
1.08
3.1
3.6
mmol/l
1.3
1.2
0.88
103
1110
(3002523) Influenza virus A Ag [Presence] in Specimen
0
29
0.00
0.99
0.0
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
0
29
0.00
0.99
0.0
2.2
—
15.9
—
0
19
(3003740) Influenza virus B Ag [Presence] in Specimen
0
29
0.00
0.99
0.0
1.1
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
140
1332
1.77
0.93
22.3
11.7
umol/l
72.1
68.3
1.04
140
1332
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
7
129
0.52
0.93
1.3
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
52
426
1.34
0.89
3.3
3.3
ng/l
28.4
19.6
0.40
28
247
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
6
31
1.97
0.85
3.5
1.2
ug/l
134.8
233.6
—
6
26
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
116
1235
0.73
0.80
4.1
4.2
mmol/l
5.6
5.8
1.08
109
1134
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
25
0.00
0.80
0.0
1.4
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
26
0.00
0.79
0.0
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
27
0.00
0.78
0.0
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
27
0.00
0.78
0.0
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
66
568
1.29
0.78
2.3
2.2
nmol/l
70.2
76.6
1.51
56
505
(3022313) Gas panel - Capillary blood
6
34
1.80
0.77
4.8
4.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
39
313
1.33
0.76
1.4
1.5
nmol/l
21.6
23.1
0.26
32
272
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
21
282
0.70
0.74
1.2
1.3
iu/ml
150.5
35.5
—
6
89
(40761511) CBC panel - Blood by Automated count
140
1344
1.63
0.72
17.6
10.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
10
61
1.69
0.70
1.3
1.9
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14
94
1.54
0.69
6.1
3.3
u/l
215.9
241.2
0.51
14
89
(36660697) Celiac disease serology panel - Serum
8
128
0.60
0.67
1.0
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
28
219
1.34
0.65
4.4
3.7
ng/l
483.0
66.6
0.66
22
154
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
102
0.57
0.65
1.3
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
13
88
1.52
0.63
1.7
1.2
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3009343) pH of Capillary blood
8
53
1.54
0.59
4.4
3.4
—
7.4
—
0
8
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
21
159
1.37
0.59
1.9
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
23
0.00
0.59
0.0
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
23
0.00
0.59
0.0
1.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
8
55
1.48
0.57
4.8
3.3
kpa
5.0
5.2
—
8
49
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
22
280
0.75
0.56
1.1
1.3
u/ml
46.7
9.1
—
7
112
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
13
92
1.45
0.52
4.2
3.1
pmol/l
4.2
4.5
0.47
13
82
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
140
1356
1.49
0.52
13.0
8.2
u/l
22.2
22.6
0.15
135
1304
(3037522) Nuclear Ab [Titer] in Serum
15
200
0.72
0.52
1.3
1.3
—
479.1
—
0
43
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
78
851
0.83
0.52
2.9
2.8
u/l
41.1
37.4
0.17
71
796
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
12
165
0.70
0.49
1.2
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
29
349
0.79
0.49
1.5
1.6
mmol/l
1.3
1.3
0.00
24
302
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
7
49
1.45
0.46
1.3
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
31
1.63
0.43
1.0
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
18
141
1.31
0.42
1.2
1.5
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
5
32
1.58
0.42
9.0
2.2
u/ml
8.4
16.5
—
5
27
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
5
32
1.58
0.42
2.0
1.5
ug/l
0.9
1.4
—
5
25
(3009214) Lutropin [Units/volume] in Serum or Plasma
5
33
1.53
0.41
1.4
1.2
u/l
23.2
13.7
—
5
27
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
5
33
1.53
0.41
1.0
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.1
—
13.7
—
0
15
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
16
0.00
0.41
0.0
2.1
—
13.4
—
0
16
(3037756) Immunofixation for Serum or Plasma
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
8
60
1.35
0.41
1.1
1.4
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
17
0.00
0.41
0.0
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
12
156
0.75
0.36
2.2
1.9
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
26
219
1.23
0.36
1.4
1.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
42
1.45
0.36
1.0
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
6
42
1.45
0.36
2.3
2.6
g/l
1.3
1.5
—
6
37
(3021879) Hepatitis B virus core Ab [Presence] in Serum
11
82
1.37
0.35
1.2
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
27
315
0.83
0.35
1.5
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
18
146
1.26
0.34
1.3
1.3
—
—
—
0
0
(4010399)
6
89
0.66
0.34
1.2
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
11
83
1.35
0.33
5.3
1.8
ml/min/173m2
47.2
67.4
—
5
34
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
38
336
1.18
0.32
1.4
1.3
u/ml
0.6
1.2
1.06
18
92
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
123
1188
1.20
0.32
18.3
9.2
ml/min/173m2
85.2
84.3
0.17
109
933
(3013512) EKG study
27
311
0.84
0.31
3.0
3.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
57
1.24
0.29
1.1
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
25
288
0.84
0.29
2.7
2.1
umol/l
310.5
6671.7
1.59
20
252
(3013139) Helicobacter pylori Ag [Presence] in Stool
9
117
0.75
0.28
1.0
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
31
273
1.17
0.28
1.3
1.9
—
—
—
0
0
(3019225) pH of Specimen
12
95
1.29
0.27
3.3
3.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
121
1245
0.85
0.27
5.7
5.1
mu/l
1.9
1.8
0.20
109
1152
(3004588) Protein electrophoresis panel - Serum or Plasma
5
73
0.67
0.26
1.4
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
104
1078
0.89
0.24
5.2
4.3
pmol/l
14.5
14.5
0.09
94
996
(1761868) Lipid panel - Serum or Plasma
50
462
1.12
0.23
2.2
2.7
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
5
38
1.33
0.23
1.6
1.7
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
7
95
0.72
0.23
1.1
1.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
40
1.26
0.22
1.0
1.3
—
—
—
0
0
(3036489) Thrombin time
5
41
1.23
0.22
1.8
1.9
s
19.4
20.2
—
5
35
(40768443) Skin Pathology biopsy report
5
42
1.20
0.21
1.2
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(4198724)
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.4
—
1.9
—
0
10
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
0
12
0.00
0.21
0.0
2.4
—
55.4
—
0
12
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
118.8
—
0
12
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
29
320
0.88
0.19
4.1
3.1
mg/l
105.5
486.2
0.62
20
193
(42529406) Shigella sp [Presence] in Stool by Culture
7
58
1.22
0.18
1.1
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
33
359
0.90
0.18
4.0
2.9
mmol/l
6.3
7.0
0.64
27
291
(3020682) Albumin/Creatinine [Ratio] in Urine
31
337
0.90
0.16
5.5
3.8
mg/mmol
22.2
4.9
1.01
22
201
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
56
532
1.08
0.15
2.0
1.9
pmol/l
96.8
98.5
0.11
29
260
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
19
211
0.89
0.14
1.6
1.9
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
9
106
0.84
0.13
1.3
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
27
288
0.92
0.09
1.6
1.3
g/l
1.9
2.3
1.23
14
171
(3045414) Leukocytes [Presence] in Urine
5
47
1.07
0.09
3.2
1.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
16
175
0.90
0.09
1.3
1.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
6
55
1.09
0.09
2.0
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
57
1.05
0.08
1.2
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94
921
1.06
0.08
3.5
3.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
11
98
1.13
0.08
1.0
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
31
295
1.06
0.07
2.0
1.7
mg/l
5.1
0.9
0.79
23
225
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
8
94
0.84
0.07
1.3
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
8
94
0.84
0.07
1.3
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
28
290
0.96
0.03
4.3
4.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
120
1190
1.04
0.03
20.1
12.6
%
38.5
39.5
1.66
94
899
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
13
129
1.01
0.00
1.2
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
18
183
0.98
0.00
1.1
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
18
185
0.97
0.00
1.5
1.8
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
7
70
1.00
0.00
2.0
2.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3004451) EKG impression Narrative
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
6
68
0.88
0.00
1.8
1.4
mu/l
449.2
327.4
—
6
61
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
5
52
0.96
0.00
1.8
3.0
%
48.0
44.4
—
5
52
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.6
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
7
0.00
0.00
0.0
2.1
—
10.2
—
0
7
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000492) Spirometry study
8
88
0.90
0.00
2.0
1.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
6
0.00
0.00
0.0
2.0
—
115.2
—
0
6
(21491868) Cryoglobulin [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
28.2
—
0
6
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
7
0.00
0.00
0.0
1.0
—
5.8
—
0
7
(3051593) INR in Capillary blood by Coagulation assay
0
7
0.00
0.00
0.0
23.7
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
8.7
—
0
7
(3002619) Bacteria identified in Specimen by Culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.2
—
18.2
—
0
6
(3045142) Bone marrow Pathology biopsy report
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
8
79
1.01
0.00
2.4
2.4
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
48.0
—
0
6
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
7
74
0.94
0.00
1.0
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
7.3
—
0
6
(44806420)
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
5
54
0.92
0.00
1.6
2.3
%
1.6
1.1
—
5
54
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
7.8
—
0.7
—
0
6
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_CERVIX_ADENO_EXALLC – Adenocarcinomas of cervix, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).